Nexavar Tablet - Sorafenib Tosylate Light Yellow Oval Film-coated, Oral Multi-kinase Inhibitor For Advanced Cancer Treatment

Get Latest Price

In Stock

Product Specifications

Indication	Advanced renal cell carcinoma, hepatocellular carcinoma, thyroid carcinoma
Salt Composition	Sorafenib Tosylate
Dosage Form	Tablet
Feature	Other, Oral multi-kinase inhibitor for advanced cancer treatment
Ingredients	Other , Sorafenib tosylate and excipients
Application	Other, Cancer treatment
Physical Color/Texture	Other , Light yellow, oval-shaped film-coated tablet
Fermentation Smell	Other, Odorless
Storage Instructions	Store below 30AdegC in a dry place
Shelf Life	24 months
Supply Ability	30 Per Day
Delivery Time	1 Week
Sample Available	Yes
Main Export Market(s)	Central America, South America, Eastern Europe, Australia, North America, Africa, Asia, Middle East, Western Europe
Main Domestic Market	All India

Company Details

Business Type

Exporter, Distributor, Trading Company

Employee Count

Establishment

1991

Working Days

Monday To Sunday

GST NO

27AARFP5752B1Z1

More Products From This Seller

Altraz Anastrozole Tablet - Anastrozole 1 mg, White Round Tablets | Aromatase Inhibitor, Breast Cancer Treatment, Oral Antineoplastic

Anti Cancer Medicines - Hepcinat 400mg

Soranib Tablets - Sorafenib 200 mg, Light Yellow Film-Coated | Oral Targeted Therapy, Multi-Kinase Inhibitor, Anticancer Medication

Methotraxate Tablet - Methotrexate BP/USP, Yellow Round Film-Coated, 2.5-25 mg | Accurate Composition, Safe Packaging, Antineoplastic, Psoriasis, Rheumatoid Arthritis

Alphalan Tablet - Advanced Formula | Supports Brain Function, Enhances Memory Retention, Boosts Cognitive Performance

Pemnat Vial Drugs

Teravir Tablet

Careprost Eye Drops - 3ml Bottle | Enhances Eyelash Growth, Promotes Eye Health

Ixempra Medicines - Ixabepilone 45 mg Injection, Clear Colorless to Pale Yellow Liquid | Cytotoxic Agent, Ready-to-Use, Breast Cancer Therapy

Irinotecan Injection - 20 mg/ml , Chemotherapy Agent - Precision Targeting for Oncology Treatments

Seller Details

Prissm Pharma

GST - 27AARFP5752B1Z1

Mumbai, Maharashtra

Accepts only Foreign inquiries

Proprietor

Mr Amith Dhiraj Galaa

Members since

11 Years

Address

12/B, Thacker Industrial Estate, N. M. Joshi Marg, Lower Parel (E), Mumbai, Maharashtra, 400011, India

nexavar in Mumbai

Report incorrect details

Recommended Products

Compare With Similar Products

Product Name

Nexavar Tablet

Sorafenib Tablets

Buyer Feedback

Indication

Advanced renal cell carcinoma, hepatocellular carcinoma, thyroid carcinoma

Used for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma.

Salt Composition

Sorafenib Tosylate

Sorafenib 200 mg

Dosage Form

Tablet

Tablets

Feature

Other, Oral multi-kinase inhibitor for advanced cancer treatment

Other, Prescription medicine, oral administration

Ingredients

Other , Sorafenib tosylate and excipients

Other , Sorafenib Tosylate and excipients

Application

Other, Cancer treatment

Other, Oncology, Cancer Chemotherapy

Physical Color/Texture

Other , Light yellow, oval-shaped film-coated tablet

Other , Light yellow, round-shaped film-coated tablets

Fermentation Smell

Other, Odorless

Other, Odorless/Not applicable

Storage Instructions

Store below 30AdegC in a dry place

Store at cool and dry place.

Shelf Life

24 months

2 Years

Supply Ability

30 Per Day

500000 Per Month

Delivery Time

1 Week

5 Days

Main Export Market(s)

Central America, South America, Eastern Europe, Australia, North America, Africa, Asia, Middle East, Western Europe

Australia, North America, Eastern Europe, Middle East, Africa, Central America, South America, Western Europe, Asia

Main Domestic Market

All India

Himachal Pradesh, Nagaland, Uttarakhand, Daman and Diu, Lakshadweep, Madhya Pradesh, West India, Rajasthan, South India, Tamil Nadu, Meghalaya, Karnataka, Goa, Maharashtra, West Bengal, Pondicherry, Gujarat, Sikkim, Arunachal Pradesh, Manipur, Delhi, Mizoram, Assam, Punjab, Haryana, East India, Jammu and Kashmir, Bihar, Telangana, Kerala, Odisha, Andaman and Nicobar Islands, Uttar Pradesh, Tripura, Jharkhand, Chandigarh, Dadra and Nagar Haveli, Andhra Pradesh, North India, Central India, Chhattisgarh, All India

Sold By

Prissm Pharma
Mumbai, Maharashtra

Saintroy Lifescience Llp
Surat, Gujarat